Drug Profile
Research programme: molecularly-cloaked antiretrovirals - Sequoia
Alternative Names: Molecularly-cloaked antiretrovirals research programme - Sequoia; SPI 70014; SPI-30014; SPI-30014C; SPI-70038; SPI-70038CLatest Information Update: 11 May 2011
Price :
$50
*
At a glance
- Originator Sequoia Pharmaceuticals
- Class Peptides; Recombinant fusion proteins
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 19 Nov 2004 Preclinical trials in HIV infections treatment in USA (Injection)